Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
ARYx Therapeutics, Inc. (ARYX)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
03/22/2011
8-K
Quarterly results
03/11/2011
8-K
Form 8-K - Current report
03/09/2011
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
"
ARYX THERAPEUTICS INFORMED OF ADDITIONAL DELAY BY FDA AND BEGINS WIND-DOWN OF OPERATIONS
"
02/17/2011
8-K
Other Events
02/07/2011
8-K
Form 8-K - Current report
12/21/2010
8-K
Form 8-K - Current report
12/16/2010
8-K
Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs:
"
ARYX THERAPEUTICS PROVIDES UPDATE ON COMPANY STATUS
"
11/26/2010
8-K
Form 8-K - Current report
11/15/2010
8-K
Quarterly results
Docs:
"
ARYX THERAPEUTICS REPORTS THIRD QUARTER RESULTS
"
10/08/2010
8-K
Form 8-K - Current report
08/16/2010
8-K
Form 8-K - Current report
06/03/2010
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
"
Separation and Consulting Agreement, by and between ARYx Therapeutics, Inc. and Peter G. Milner, M.D
",
"
ARYX ANNOUNCES RESIGNATION OF PETER G. MILNER, PRESIDENT RESEARCH AND DEVELOPMENT
"
05/20/2010
8-K
Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs:
"
Opinion of Cooley LLP
",
"
At Market Instrument Sales Agreement, by and among ARYx Therapeutics, Inc., McNicoll, Lewis & Vlak LLC, and Wm Smith & Co
"
05/13/2010
8-K
Quarterly results
Docs:
"
ARYX REPORTS FIRST QUARTER 2010 RESULTS OF OPERATIONS - ATI-7505 End of Phase 2 Meeting Held
"
04/09/2010
8-K
Form 8-K - Current report
03/29/2010
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs:
"
ARYX REPORTS FOURTH QUARTER AND FULL YEAR 2009 RESULTS OF OPERATIONS
"
03/03/2010
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/19/2010
8-K
Form 8-K - Current report
01/05/2010
8-K
Other Events, Financial Statements and Exhibits
Docs:
"
ARYx Therapeutics Receives Guidance on Anticoagulant Agent Tecarfarin
"
11/12/2009
8-K
Form 8-K - Current report
08/13/2009
8-K
Form 8-K - Current report
07/08/2009
8-K
Other Events, Financial Statements and Exhibits
Docs:
"
ARYx Therapeutics Announces Results of Phase 2/3 Clinical Trial on Anticoagulant Agent Tecarfarin
"
05/27/2009
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
"
ARYX THERAPEUTICS, INC. EXECUTIVE SEVERANCE BENEFIT PLAN Section 1. INTRODUCTION.
"
05/14/2009
8-K
Form 8-K -- Current report
03/26/2009
8-K
Form 8-K -- Current report
02/24/2009
8-K
Form 8-K -- Current report
02/10/2009
8-K
Form 8-K -- Current report
01/12/2009
8-K
Form 8-K -- Current report
12/18/2008
8-K
Form 8-K -- Current report
11/28/2008
8-K
Unregistered Sales of Equity Securities
11/17/2008
8-K
Form 8-K -- Current report
11/12/2008
8-K
Quarterly results
Docs:
"
Registration Rights Agreement, by and among ARYx Therapeutics, Inc. and the investors identified on the signature pages thereto
",
"
Form of Warrant to Purchase Shares of Common Stock
",
"
Securities Purchase Agreement, by and among ARYx Therapeutics, Inc. and the purchasers identified on the signature pages thereto
",
"
ARYx REPORTS THIRD QUARTER 2008 FINANCIAL RESULTS As a Result of Recent Clinical, Strategic and Financial Progress ARYx is Well Positioned to Achieve its Corporate Milestones
"
10/23/2008
8-K
Form 8-K -- Current report
08/29/2008
8-K
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy